The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma

Objective This paper presents a preliminary experience based on the "one-to-many" approach of the Shiny method. Numerous (or "many") treatments for advanced or metastatic urothelial carcinoma have recently been reviewed. More recently, "one" potentially innovative treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Messori, Andrea, Rivano, Melania, Cancanelli, Luca, Damuzzo, Vera, Ossato, Andrea, Chiumente, Marco, Mengato, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508613/
https://www.ncbi.nlm.nih.gov/pubmed/36171827
http://dx.doi.org/10.7759/cureus.28369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508613/
https://www.ncbi.nlm.nih.gov/pubmed/36171827
http://dx.doi.org/10.7759/cureus.28369

Ejemplares similares